https://www.selleckchem.com/products/cvt-313.html
A DIstal Cholangiocarcinoma Early Recurrence Score was developed according to each factor available prior to surgery [NLR 9.0 (2 points); peak T-bil 1.5 mg/dL (1 points); MVR (2 points)]. Cumulative ER rates incrementally increased among patients who were low (0 points; 10.6%), intermediate (1-2 points; 26.8%), or high (3-5 points; 57.6%) risk (p 0.001) in the training dataset, as well as in the validation dataset [low (0 points); 3.4%, intermediate (1-2 points); 32.7%, or high risk (3-5 points); 55.6% (p 0.001)]. Am
Like
Comment
Share
